Madison Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$211K Sell
1,722
-380
-18% -$48.3K 0.04% 148
2023
Q2
$267K Sell
2,102
-208
-9% -$27K 0.05% 141
2023
Q1
$298K Hold
2,310
0.06% 135
2022
Q4
$303K Sell
2,310
-120
-5% -$15.5K 0.07% 131
2022
Q3
$284K Buy
2,430
+127
+6% +$15.8K 0.07% 137
2022
Q2
$271K Sell
2,303
-326
-12% -$38.7K 0.07% 139
2022
Q1
$343K Sell
2,629
-205
-7% -$26.7K 0.07% 132
2021
Q4
$433K Sell
2,834
-38
-1% -$5.88K 0.09% 114
2021
Q3
$464K Hold
2,872
0.1% 112
2021
Q2
$470K Sell
2,872
-1,899
-40% -$293K 0.1% 109
2021
Q1
$718K Sell
4,771
-23,467
-83% -$3.73M 0.18% 96
2020
Q4
$4.28M Sell
28,238
-2,300
-8% -$329K 1.13% 23
2020
Q3
$4.13M Sell
30,538
-2,336
-7% -$317K 1.24% 21
2020
Q2
$4.49M Sell
32,874
-2,226
-6% -$284K 1.48% 18
2020
Q1
$3.78M Sell
35,100
-5,256
-13% -$605K 1.52% 20
2019
Q4
$4.86M Buy
+40,356
New +$4.5M 1.4% 20

Other funds holding IBB

Madison Wealth Management's IBB Position: Q3 2023 in Review

Madison Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q3 2023, selling an estimated $48.3K and leaving 1,722 shares worth $211K. The position accounts for 0.04% of the portfolio, ranked #148.

Madison Wealth Management first reported a position in IBB in Q4 2019 and has held it in 16 quarters since. The position peaked at $4.86M in Q4 2019. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

  • Madison Wealth Management held 1,722 shares of iShares Biotechnology ETF worth $211K as of Q3 2023.
  • Madison Wealth Management sold 380 iShares Biotechnology ETF shares in Q3 2023, an estimated $48.3K.
  • iShares Biotechnology ETF made up 0.04% of Madison Wealth Management's portfolio in Q3 2023, its #148 holding.
  • Madison Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 16 quarters since.
  • Madison Wealth Management's iShares Biotechnology ETF position peaked at $4.86M in Q4 2019.
  • 833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Madison Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.